BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 24078660)

  • 1. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ledermann JA; Raja FA; Fotopoulou C; Gonzalez-Martin A; Colombo N; Sessa C;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi24-32. PubMed ID: 24078660
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Colombo N; Peiretti M; Parma G; Lapresa M; Mancari R; Carinelli S; Sessa C; Castiglione M;
    Ann Oncol; 2010 May; 21 Suppl 5():v23-30. PubMed ID: 20555088
    [No Abstract]   [Full Text] [Related]  

  • 3. Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Aebi S; Castiglione M;
    Ann Oncol; 2009 May; 20 Suppl 4():21-3. PubMed ID: 19454452
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Senkus E; Kyriakides S; Penault-Llorca F; Poortmans P; Thompson A; Zackrisson S; Cardoso F;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi7-23. PubMed ID: 23970019
    [No Abstract]   [Full Text] [Related]  

  • 5. Epithelial ovarian cancer.
    Al-Niaimi AN; Ahmed M; Petersen CB
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):269-83. PubMed ID: 22640715
    [No Abstract]   [Full Text] [Related]  

  • 6. BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.
    Coakley M; Cleary V; Power N; O'Reilly S
    Eur J Hum Genet; 2017 Feb; 25(2):167-168. PubMed ID: 27759028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pay more attention to the surveillance and deal with the recurrence in ovarian cancer].
    Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):657-8. PubMed ID: 14989220
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of epithelial ovarian cancer: overdue for a major rethink.
    Hoskins P
    Curr Oncol Rep; 2013 Jun; 15(3):204-6. PubMed ID: 23483376
    [No Abstract]   [Full Text] [Related]  

  • 9. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Colombo N; Preti E; Landoni F; Carinelli S; Colombo A; Marini C; Sessa C;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi33-8. PubMed ID: 24078661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
    Wu XF; Chen HZ; Han DF
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):664-6. PubMed ID: 14728851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
    Chung C; Lee R
    J Oncol Pharm Pract; 2017 Sep; 23(6):454-469. PubMed ID: 27357817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of second-look laparotomy for surgically confirmed early-stage epithelial ovarian cancer: a multicenter retrospective study.
    Sato N; Akahira J; Kitamura T; Aoki M; Yoshinaga K; Okamura C; Utsunomiya H; Shimizu T; Niikura H; Ito K; Okamura K; Yaegashi N
    Int J Clin Oncol; 2003 Feb; 8(1):40-4. PubMed ID: 12601541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.
    Geurts SM; van Altena AM; de Vegt F; Tjan-Heijnen VC; Massuger LF; van Dijck JA; Verbeek AL
    Int J Gynecol Cancer; 2011 May; 21(4):647-53. PubMed ID: 21543930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions in the management of epithelial ovarian cancer.
    Blagden S; Gabra H
    Future Oncol; 2008 Jun; 4(3):403-11. PubMed ID: 18518765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the diagnosis and treatment of ovarian cancer.
    Jelovac D; Armstrong DK
    CA Cancer J Clin; 2011; 61(3):183-203. PubMed ID: 21521830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to follow-up patients with epithelial ovarian cancer.
    Miller RE; Rustin GJ
    Curr Opin Oncol; 2010 Sep; 22(5):498-502. PubMed ID: 20498597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whence High-Grade Serous Ovarian Cancer.
    Kohn EC; Ivy SP
    Am Soc Clin Oncol Educ Book; 2017; 37():443-448. PubMed ID: 28561656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines.
    Colombo N; Ledermann JA;
    Ann Oncol; 2021 Oct; 32(10):1300-1303. PubMed ID: 34293462
    [No Abstract]   [Full Text] [Related]  

  • 20. The different impact of BRCA mutations on the survival of epithelial ovarian cancer patients: a retrospective single-center experience.
    Lorusso D; Cirillo F; Mancini M; Spatti GB; Grijuela B; Ditto A; Raspagliesi F
    Oncology; 2013; 85(2):122-7. PubMed ID: 23941904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.